Attribution Statement: LactMed is a registered trademark of the U.S. Department of Health and Human Services.
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006-.
CASRN: 1000120-98-8
Drug Levels and Effects
Summary of Use during Lactation
Mipomersen marketing has been discontinued in the United States. No relevant published information exists with the use of mipomersen during breastfeeding. Because of a concern with disruption of infant lipid metabolism, mipomersen should not be used during breastfeeding.
Drug Levels
Maternal Levels. Relevant published information was not found as of the revision date.
Infant Levels. Relevant published information was not found as of the revision date.
Effects in Breastfed Infants
Relevant published information was not found as of the revision date.
Effects on Lactation and Breastmilk
Relevant published information was not found as of the revision date.
Alternate Drugs to Consider
Substance Identification
Substance Name
Mipomersen
CAS Registry Number
1000120-98-8
Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.
- User and Medical Advice Disclaimer
- Drugs and Lactation Database (LactMed) - Record Format
- LactMed - Database Creation and Peer Review Process
- Fact Sheet. Drugs and Lactation Database (LactMed)
- Drugs and Lactation Database (LactMed) - Glossary
- LactMed Selected References
- Drugs and Lactation Database (LactMed) - About Dietary Supplements
- Breastfeeding Links
- PubChem SubstanceRelated PubChem Substances
- Mipomersen - Drugs and Lactation Database (LactMed®)Mipomersen - Drugs and Lactation Database (LactMed®)
- vesnarinone [Supplementary Concept]vesnarinone [Supplementary Concept]Date introduced: July 23, 1984<br/>MeSH
- platonin [Supplementary Concept]platonin [Supplementary Concept]RN given refers to diiodide; structure in first source<br/>Date introduced: November 12, 1981<br/>MeSH
- Nefopam - Drugs and Lactation Database (LactMed®)Nefopam - Drugs and Lactation Database (LactMed®)
- dolastatin 10 [Supplementary Concept]dolastatin 10 [Supplementary Concept]from mollusk Dolabella auricularia; contains four amino acids, dolavaline, dolaisoleucine, dolaproine, valine and the primary amine dolaphenine; deo-dolastatin 10 is a new dol...<br/>Date introduced: July 18, 1990<br/>MeSH
Your browsing activity is empty.
Activity recording is turned off.
See more...